Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea
· Delayed Price · Currency is KRW 970.00
-36.00 (-3.58%)
At close: Mar 9, 2026
Hwail Pharmaceutical Revenue
Hwail Pharmaceutical had revenue of 27.82B KRW in the quarter ending March 31, 2017, a decrease of -11.58%. This brings the company's revenue in the last twelve months to 107.87B, down -4.84% year-over-year. In the year 2016, Hwail Pharmaceutical had annual revenue of 111.52B with 5.08% growth.
Revenue (ttm)
107.87B
Revenue Growth
-4.84%
P/S Ratio
0.76
Revenue / Employee
829.81M
Employees
130
Market Cap
82.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 111.52B | 5.39B | 5.08% |
| Dec 31, 2015 | 106.13B | 10.03B | 10.43% |
| Dec 31, 2014 | 96.10B | 1.94B | 2.06% |
| Dec 31, 2013 | 94.17B | 2.33B | 2.54% |
| Dec 31, 2012 | 91.83B | 13.74B | 17.59% |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinsin Pharmaceutical | 110.29B |
| GL Pharm Tech | 34.30B |
| Polaris AI Pharma | 63.94B |
| BL Pharmtech | 6.98B |
| Ahn-Gook Pharmaceutical | 300.96B |
| Daehan Nupharm | 201.59B |
| Sam-A Pharm. | 76.66B |
| Optipharm.CO.,LTD | 21.98B |